COLUMBUS REVISION KNEE SYSTEM

K122985 · Aesculap Implant System, Inc. · JWH · Oct 26, 2012 · Orthopedic

Device Facts

Record IDK122985
Device NameCOLUMBUS REVISION KNEE SYSTEM
ApplicantAesculap Implant System, Inc.
Product CodeJWH · Orthopedic
Decision DateOct 26, 2012
DecisionSESE
Submission TypeSpecial
Regulation21 CFR 888.3560
Device ClassClass 2
AttributesTherapeutic

Indications for Use

The Columbus REVISION Knee System is indicated for use in reconstruction of the diseased knee joint caused by osteoarthritis, rheumatoid arthritis, post-traumatic arthritis, the need to revise failed arthroplasties or osteotomies where pain, deformity, or dysfunction persist, and for patients suffering from corrective valgus or varus deformity and moderate flexion contracture. The Columbus REVISION Knee System is designed for use with bone cement.

Device Story

Semi-constrained cemented knee prosthesis system for reconstructive surgery and revision cases. Components include femoral and tibial augments, stems, and tibial gliding surfaces. Materials: CoCrMo, UHMWPE (tibial gliding surfaces), PEEK (tibial mask); optional ZrN coating. Used in clinical settings by orthopedic surgeons. Device replaces diseased knee joint surfaces to restore function and reduce pain. Modification involves design change to posterior stabilizing (PS) tibial post of medium and high constraint inserts.

Clinical Evidence

Bench testing only. Endurance testing performed on tibial gliding surfaces, tibial post, and fixation screw for 10 million cycles per ASTM F 2722-08. Results demonstrated performance similar to the predicate device.

Technological Characteristics

Semi-constrained cemented prosthesis. Materials: CoCrMo, UHMWPE, PEEK. Optional ZrN coating. Components: femoral/tibial augments, stems, inserts. Testing per ASTM F 2722-08. Sterile, single-use.

Indications for Use

Indicated for patients requiring knee joint reconstruction due to osteoarthritis, rheumatoid arthritis, post-traumatic arthritis, failed arthroplasties, or failed osteotomies with persistent pain, deformity, or dysfunction; also for patients with correctable valgus/varus deformity and moderate flexion contracture.

Regulatory Classification

Identification

A knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis is a device intended to be implanted to replace a knee joint. The device limits translation and rotation in one or more planes via the geometry of its articulating surfaces. It has no linkage across-the-joint. This generic type of device includes prostheses that have a femoral component made of alloys, such as cobalt-chromium-molybdenum, and a tibial component or components and a retropatellar resurfacing component made of ultra-high molecular weight polyethylene. This generic type of device is limited to those prostheses intended for use with bone cement (§ 888.3027).

Predicate Devices

Reference Devices

Submission Summary (Full Text)

{0}------------------------------------------------ K122985 Page 1 of 2 #### 510(k) SUMMARY OF SAFETY AND EFFECTIVENESS B. Columbus REVISION Knee System October 24, 2012 Aesculap® Implant Systems, LLC COMPANY: 3773 Corporate Parkway Center Valley, PA 18034 ESTABLISHMENT REGISTRATION NUMBER: 3005673311 CONTACT: Julie Tom Wing 610-984-9147 (phone) 610-791-6882 (fax) Julie. TomWing@aesculap.com ### DEVICE | TRADE NAME: | REVISION | |----------------------|-------------------------------------------------------------------------------------------------| | COMMON NAME: | Columbus REVISION Knee System | | DEVICE CLASS: | CLASS II | | PRODUCT CODE: | JWH | | REGULATION NUMBER: | 888.3560 | | CLASSIFICATION NAME: | Knee Joint Patellofemorotibial<br>Polymer/Metal/Polymer Semi-constrained<br>Cemented Prosthesis | #### SUBSTANTIAL EQUIVALENCE Aesculap Implant Systems, LLC believes that the modification to Columbus REVISION Knee System remains substantially equivalent to Aesculap Implant Systems Columbus REVISION Knee System originally cleared in 510(K) K083772. ### DEVICE DESCRIPTION The cemented Columbus REVISION Knee System is a semi-constrained cemented prosthesis system. The system offers femoral and tibial augments as well as stems to provide options for use during reconstructive surgery, particularly revision cases. The system is manufactured from CoCrMo with the exception of the tibial "gliding surfaces" which are manufactured from UHMWPE and the tibial mask which is made of PEEK. The system is made up of numerous components available in various sizes. All components are sterile and for single use only. All components manufactured from CoCrMo are also available with a ZrN (Zirconium nitride) coating which has been cleared in Aesculap Columbus AS Knee submission (K071220) and described in cleared Columbus Revision submission (K083772). OCT 26 2012 {1}------------------------------------------------ K122985 Page 2 of 2 #### INDICATIONS FOR USE The Columbus REVISION Knee System is indicated for use in reconstruction of the diseased knee joint caused by osteoarthritis, rheumatoid arthritis, post-traumatic arthritis, the need to revise failed arthroplasties or osteotomies where pain, deformity, or dysfunction persist, and for patients suffering from corrective valgus or varus deformity and moderate flexion contracture. The Columbus REVISION Knee System is designed for use with bone cement. #### TECHNOLOGICAL CHARACTERISTICS (Compared to the Predicate) The entire Columbus REVISION Knee System was cleared under K083772. The fundamental scientific technology and materials for the Columbus REVISION Knee System remain the same. The only difference is a design modification of the posterior stabilizing (PS) tibial post of the medium constraint (MC) and high constraint (HC) gliding surfaces (inserts). ### PERFORMANCE DATA Customized endurance testing based on ASTM F 2722-08 was performed on Aesculap Implant Systems Columbus REVISION tibial gliding surfaces, tibial post and fixation screw for 10 million cycles as a result of the risk assessment. The results were found to be similar to the legally marketed Columbus REVISION Knee System. {2}------------------------------------------------ Image /page/2/Picture/1 description: The image shows the logo for the U.S. Department of Health and Human Services. The logo features a stylized eagle with three lines forming its body and wings. The words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" are arranged in a circular pattern around the eagle. Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002 Aesculan Implant System, Incorporated % Ms. Julie Tom Wing Regulatory Affairs Specialist 3773 Corporate Parkway Center Valley, Pennsylvania 18034 Re: K122985 Trade/Device Name: Columbus REVISION Knee System Regulation Number: 21 CFR 888.3560 Regulation Name: Knee joint patellofemorotibial polymer/metal/polymer semi-constrained cemented prosthesis Regulatory Class: Class II Product Code: JWH Dated: September 20, 2012 Received: September 26, 2012 Dear Ms. Wing: We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading. If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical {3}------------------------------------------------ ## Page 2 - Ms. Julie Tom Wing device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050. If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance. You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address http://www.fda.gov/MedicalDevices/Resourcesfor You/Industry/default.htm. Sincerely yours. Mark N. Melkerson Director Division of Surgical, Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health Enclosure {4}------------------------------------------------ Page 1 of 1 #### INDICATIONS FOR USE STATEMENT A. 1122985 510(k) Number:________________________________________________________________________________________________________________________________________________________________ # Device Name: Columbus REVISION Knee System #### Indications for Use: The Columbus REVISION Knee System is indicated for use in reconstruction of the diseased knee joint caused by osteoarthritis, rheumatoid arthritis, post-traumatic arthritis, the need to revise failed arthroplasties or osteotomies where pain, deformity or dysfunction persist, and for patients suffering from correctable valgus or varus deformity and moderate flexion contracture. The Columbus REVISION Knee System is designed to for use with bone cement. | Prescription Use | X | |-----------------------------|---| | and/or Over-the-Counter Use | | (per 21 CFR 801 109) (PLEASE DO NOT WRITE BELOW THIS LINE - CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE) (Division Sign-Off) Division of Surgical, Orthopedic, and Restorative Devices 510(k) Number k122988 002
Innolitics

Panel 1

/
Ready

Predicate graph will load when search results are available.

Embedding visualization will load when search results are available.

PDF viewer will load when search results are available.

Loading panels...

Select an item from Submissions

Click any panel, subpart, regulation, product code, or device to see details here.

Section Matches

Results will appear here.

Product Code Matches

Results will appear here.

Special Control Matches

Results will appear here.

Loading collections...